These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 37277772)

  • 1. Policymakers' and healthcare providers' perspectives on the introduction of oral pre-exposure prophylaxis for key populations in Ghana.
    Nagai H; Adiibokah E; Tagoe H; Tun W; Pilgrim NA; Ankomah A; Rahman YAA; Addo SA; Atuahene SK; Essandoh E; Maher S; Kowalski M
    BMC Public Health; 2023 Jun; 23(1):1065. PubMed ID: 37277772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and facilitators to pre-exposure prophylaxis uptake among male sex workers in Mexico: an application of the RE-AIM framework.
    Kadiamada-Ibarra H; Hawley NL; Sosa-Rubí SG; Wilson-Barthes M; Franco RR; Galárraga O
    BMC Public Health; 2021 Nov; 21(1):2174. PubMed ID: 34837988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers and facilitators to uptake and persistence on prep among key populations in Southern Province, Zambia: a thematic analysis.
    Stoebenau K; Muchanga G; Ahmad SS; Bwalya C; Mwale M; Toussaint S; Maambo C; Peters CJ; Baumhart C; Mwango LK; Lavoie MC; Claassen CW
    BMC Public Health; 2024 Jun; 24(1):1617. PubMed ID: 38886691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey.
    Belludi A; McFall AM; Solomon SS; Celentano DD; Mehta SH; Srikrishnan AK; Kumar MS; Solomon S; Lucas GM
    PLoS One; 2021; 16(2):e0247352. PubMed ID: 33630909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Communication needs for improved uptake of PrEP and HIVST services among key populations in Nigeria: a mixed-method study.
    Durosinmi-Etti O; Nwala EK; Oki F; Ikpeazu A; Godwin E; Umoh P; Shaibu A; Ogundipe A; Kalaiwo A
    AIDS Res Ther; 2021 Nov; 18(1):88. PubMed ID: 34801037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge and Acceptability of HIV pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in Ghana.
    Ogunbajo A; Leblanc NM; Kushwaha S; Boakye F; Hanson S; Smith MDR; Nelson LE
    AIDS Care; 2020 Mar; 32(3):330-336. PubMed ID: 31597455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-exposure prophylaxis for transgender women and men who have sex with men: qualitative insights from healthcare providers, community organization-based leadership and end users in coastal Kenya.
    Kimani M; Sanders EJ; Chirro O; Mukuria N; Mahmoud S; Rinke de Wit TF; Graham SM; Operario D; van der Elst EM
    Int Health; 2022 May; 14(3):288-294. PubMed ID: 34325469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Readiness for Use of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men in Malawi: Qualitative Focus Group and Interview Study.
    Mpunga E; Persaud N; Akolo C; Boyee D; Kamanga G; Trapence G; Chilongozi D; Ruberintwari M; Masankha Banda L
    JMIR Public Health Surveill; 2021 Oct; 7(10):e26177. PubMed ID: 34228627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low- and middle-income countries: a systematic review and meta-analysis.
    Yi S; Tuot S; Mwai GW; Ngin C; Chhim K; Pal K; Igbinedion E; Holland P; Choub SC; Mburu G
    J Int AIDS Soc; 2017 Jun; 20(1):21580. PubMed ID: 28691439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experiences of men who have sex with men when initiating, implementing and persisting with HIV pre-exposure prophylaxis.
    Gillespie D; Wood F; Williams A; Ma R; de Bruin M; Hughes DA; Jones AT; Couzens Z; Hood K
    Health Expect; 2022 Aug; 25(4):1332-1341. PubMed ID: 35426223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards a fair consideration of PrEP as part of combination HIV prevention in Latin America.
    Ravasi G; Grinsztejn B; Baruch R; Guanira JV; Luque R; Cáceres CF; Ghidinelli M
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21113. PubMed ID: 27760687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community perspectives on barriers and challenges to HIV pre-exposure prophylaxis access by men who have sex with men and female sex workers access in Nigeria.
    Emmanuel G; Folayan M; Undelikwe G; Ochonye B; Jayeoba T; Yusuf A; Aiwonodagbon B; Bilali C; Umoh P; Ojemeiri K; Kalaiwo A
    BMC Public Health; 2020 Jan; 20(1):69. PubMed ID: 31941469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using a HIV prevention cascade for identifying missed opportunities in PrEP delivery in Kenya: results from a programmatic surveillance study.
    Were D; Musau A; Mutegi J; Ongwen P; Manguro G; Kamau M; Marwa T; Gwaro H; Mukui I; Plotkin M; Reed J
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25537. PubMed ID: 32602658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experiences and challenges of pre-exposure prophylaxis initiation and retention among high-risk populations: qualitative insights among service providers in Thailand.
    Rayanakorn A; Chautrakarn S; Intawong K; Chariyalertsak C; Khemngern P; Olson D; Chariyalertsak S
    Front Public Health; 2024; 12():1366754. PubMed ID: 38813431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of oral pre-exposure prophylaxis cessation among men who have sex with men in China: implications from a nationally quantitative and qualitative study.
    Liu Y; Wei S; Cheng Z; Xian Y; Liu X; Yang J; Liu Y; Yu M; Chen Z; Chen J; Ma J; Cui Z; Li C
    BMC Public Health; 2024 Jul; 24(1):1765. PubMed ID: 38956521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.
    Biello KB; Bazzi AR; Mimiaga MJ; Biancarelli DL; Edeza A; Salhaney P; Childs E; Drainoni ML
    Harm Reduct J; 2018 Nov; 15(1):55. PubMed ID: 30419926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PrEP for key populations: results from the first PrEP demonstration project in the Democratic Republic of the Congo.
    Franks J; Teasdale C; Olsen H; Wang C; Mushimebele N; Tenda Mazala R; Tchissambou T; Malele Bazola F; Bingham T; Djomand G; Mukinda E; Ewetola R; Abrams E; Reidy W
    AIDS Care; 2022 Mar; 34(3):359-362. PubMed ID: 34495772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge of and willingness to take pre-exposure prophylaxis among men who have sex with men in Israel.
    Zohar M; Guy S; Itzchak L
    Isr J Health Policy Res; 2021 Dec; 10(1):71. PubMed ID: 34872598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injectable Pre-Exposure Prophylaxis for HIV Prevention: Perspectives on the Benefits and Barriers from Gay, Bisexual, and Queer Men and Health System Stakeholders in Ontario, Canada.
    Grace D; Gaspar M; Wells A; Sinno J; Daroya E; Montess M; Hull M; Lachowsky NJ; Tan DHS
    AIDS Patient Care STDS; 2023 Jun; 37(6):306-315. PubMed ID: 37195728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Provider-Patient Communication on Pre-Exposure Prophylaxis (Prep) for HIV Prevention: An Exploration of Healthcare Provider Challenges.
    Wilson K; Bleasdale J; Przybyla SM
    Health Commun; 2021 Nov; 36(13):1677-1686. PubMed ID: 32633137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.